Kenneth I Chenault
CIK 1180524 · Chairman & CEO · last filed 2026-08-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AXP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
20 UNIVERSITY ROAD, 4TH FLOOR
CAMBRIDGE, MA 02138
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABNB | Director | 49,225 | $166.70 | $8.21M | -$2.67M | 9 | 2026-08-11 |
| Livongo Health, Inc. (LVGO) Delisted | 10%+ Owner | 971,064 | — | — | -$111.05M | 2 | 2020-06-26 |
| FB | Director | 3,717 | $45.78 | $170.2K | $0 | 6 | 2020-05-19 |
| IBM | Director | 8,648 | $252.94 | $2.19M | -$3.90M | 55 | 2019-01-02 |
| PG | Director | 41,010 | $158.37 | $6.49M | $65.7K | 39 | 2018-12-12 |
| AXP | Chairman & CEO | 1,196,258 | $318.22 | $380.67M | -$441.10M | 44 | 2018-01-30 |
Recent Filings · Page 16 of 16
157 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-02-16 | AXP | Mixed | +84,475 | -$3.87M | EDGAR |
| 2007-02-13 | AXP | Mixed | −690 | $0 | EDGAR |
| 2007-01-30 | AXP | Tax (F) | −36,932 | -$2.13M | EDGAR |
| 2007-01-29 | AXP | Grant (A) | +35,818 | $0 | EDGAR |
| 2007-01-26 | AXP | Tax (F) | −4,547 | -$265.0K | EDGAR |
| 2007-01-25 | AXP | Mixed | −17,451 | -$810.6K | EDGAR |
| 2007-01-03 | IBM | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.